SE432247B - Sett att framstella dihydro-cyklosporin c - Google Patents

Sett att framstella dihydro-cyklosporin c

Info

Publication number: SE432247B
Authority: SE; Sweden
Prior art keywords: cyclosporine; dihydro; make; make dihydro
Prior art date: 1975-11-04

Application number

SE7611906A

Other languages

English (en)

Swedish (sv)

Other versions

SE7611906L (sv

Inventor

A Ruegger

M Kuhn

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-11-04

Filing date

1976-10-27

Publication date

1984-03-26

1976-10-27 Application filed by Sandoz Ag filed Critical Sandoz Ag

1977-05-05 Publication of SE7611906L publication Critical patent/SE7611906L/xx

1984-03-26 Publication of SE432247B publication Critical patent/SE432247B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/885—Trichoderma
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Botany (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Transplantation (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SE7611906A 1975-11-04 1976-10-27 Sett att framstella dihydro-cyklosporin c SE432247B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH1419575A CH614931A5 (hu)	1975-11-04	1975-11-04

Publications (2)

Publication Number	Publication Date
SE7611906L SE7611906L (sv)	1977-05-05
SE432247B true SE432247B (sv)	1984-03-26

Family

ID=4398730

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SE7611906A SE432247B (sv)	1975-11-04	1976-10-27	Sett att framstella dihydro-cyklosporin c
SE8202039A SE8202039L (sv)	1975-11-04	1982-03-30	Cyklosporin c och sett att framstella denna forening

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SE8202039A SE8202039L (sv)	1975-11-04	1982-03-30	Cyklosporin c och sett att framstella denna forening

Country Status (23)

Country	Link
US (1)	US4108985A (hu)
JP (2)	JPS5259180A (hu)
AT (1)	AT359642B (hu)
AU (1)	AU513538B2 (hu)
BE (1)	BE847941A (hu)
CA (1)	CA1087609A (hu)
CH (2)	CH614931A5 (hu)
DE (2)	DE2661031C2 (hu)
DK (1)	DK148907C (hu)
ES (1)	ES452942A1 (hu)
FI (1)	FI60701C (hu)
FR (2)	FR2330387A1 (hu)
GB (2)	GB1567202A (hu)
IE (2)	IE44750B1 (hu)
IL (1)	IL50836A (hu)
NL (1)	NL7612026A (hu)
NO (1)	NO763667L (hu)
NZ (1)	NZ182496A (hu)
PH (1)	PH14725A (hu)
PT (1)	PT65791B (hu)
SE (2)	SE432247B (hu)
YU (1)	YU270076A (hu)
ZA (1)	ZA766340B (hu)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4210581A (en) *	1975-11-04	1980-07-01	Sandoz Ltd.	Organic compounds
DE2819094A1 (de) *	1977-05-10	1978-11-23	Sandoz Ag	Cyclosporin-derivate, ihre verwendung und herstellung
FR2410658A1 (fr) *	1977-11-30	1979-06-29	Science Union & Cie	Nouveau produit biologique d'origine fongique, son obtention et son application a la therapeutique
SE445174B (sv) *	1978-03-07	1986-06-09	Sandoz Ag	Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
SE448386B (sv) *	1978-10-18	1987-02-16	Sandoz Ag	Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
US4201771A (en) *	1979-03-12	1980-05-06	Merck & Co., Inc.	Antibiotic A43F
JPS5665853A (en) *	1979-11-01	1981-06-03	Sankyo Co Ltd	Mycoplanesin derivative and its preparation
EP0098456B1 (en) *	1980-02-14	1989-05-24	Sandoz Ag	Peptides comprising a (1s,2r,3r)- or (1r,2s,3s)-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptane or -hept-5-ene residue useful in the total synthesis of cyclosporins, and processes for their production
US4396542A (en) *	1980-02-14	1983-08-02	Sandoz Ltd.	Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
US4370266A (en) *	1980-04-07	1983-01-25	Sankyo Company, Limited	Mycoplanecin derivatives and their preparation
DE3260468D1 (en) *	1981-01-09	1984-09-06	Sandoz Ag	Novel cyclosporins
US5639724A (en) *	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
GB8422253D0 (en) *	1984-09-04	1984-10-10	Sandoz Ltd	Organic compounds
DE3587342T2 (de)	1984-10-04	1993-12-02	Sandoz Ag	Cyclosporine.
US4727035A (en) *	1984-11-14	1988-02-23	Mahoney Walter C	Immunoassay for cyclosporin
US4764503A (en) *	1986-11-19	1988-08-16	Sandoz Ltd.	Novel cyclosporins
US4798823A (en) *	1987-06-03	1989-01-17	Merck & Co., Inc.	New cyclosporin analogs with modified "C-9 amino acids"
DE3884470T2 (de) *	1987-06-17	1994-03-10	Sandoz Ag	Cyclosporine und deren Benutzung als Arzneimittel.
DE3888357T2 (de) *	1987-06-22	1994-09-15	Merck & Co Inc	Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
GB8717299D0 (en) *	1987-07-22	1987-08-26	Nat Res Dev	Peptides
GB8717300D0 (en) *	1987-07-22	1987-08-26	Nat Res Dev	Cyclosporins
US5227467A (en) *	1987-08-03	1993-07-13	Merck & Co., Inc.	Immunosuppressive fluorinated cyclosporin analogs
ATE109970T1 (de) *	1987-09-03	1994-09-15	Univ Georgia Res Found	Cyclosporin-augenmittel.
US4839342A (en) *	1987-09-03	1989-06-13	University Of Georgia Research Foundation, Inc.	Method of increasing tear production by topical administration of cyclosporin
US4914188A (en) *	1987-11-16	1990-04-03	Merck & Co., Inc.	Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US5236899A (en) *	1987-11-16	1993-08-17	Merck & Co., Inc.	6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
HU203564B (en) *	1987-12-21	1991-08-28	Sandoz Ag	Process for producing new orthorombos cyclosporin without solvatation
US4943560A (en) *	1988-04-06	1990-07-24	Regents Of The University Of Minnesota	Solvent system for chronic vascular infusion of hydrophobic drugs
US5342625A (en) *	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) *	1989-02-20	2006-07-25	Novartis Ag	Cyclosporin galenic forms
US5540931A (en) *	1989-03-03	1996-07-30	Charles W. Hewitt	Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) *	1989-03-03	1991-02-26	The Regents Of The University Of California	Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en)	1989-07-24	1989-09-06	Sandoz Ltd	Improvements in or relating to organic compounds
US5122511A (en) *	1990-02-27	1992-06-16	Merck & Co., Inc.	Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5447854A (en) *	1991-01-25	1995-09-05	Fujisawa Pharmaceutical Co., Ltd.	Production of cyclosporin A and/or C with a strain of NECTRIA
ES2065273B1 (es) *	1993-05-25	1995-09-16	Biogal Gyogyszergyar	Procedimiento para la purificacion de ciclosporina a.
US5709797A (en) *	1996-06-05	1998-01-20	Poli Industria Chimica S.P.A.	Method of isolating cyclosporins
TR199901686T2 (xx) *	1997-01-30	1999-09-21	Norvartis Ag	Esasen ya�s�z farmakolojik kompozisyonlar� i�eren sert jelatin kaps�ller.
US6346511B1 (en)	1997-09-08	2002-02-12	Panacea Biotec Limited	Pharmaceutical composition comprising cyclosporin
IN188719B (hu) *	1997-09-08	2002-11-02	Panacea Biotec Ltd
US6187747B1 (en)	1997-09-08	2001-02-13	Panacea Biotech Limited	Pharmaceutical composition comprising cyclosporin
US6008191A (en) *	1997-09-08	1999-12-28	Panacea Biotec Limited	Pharmaceutical compositions containing cyclosporin
DE69840586D1 (de)	1997-10-08	2009-04-02	Isotechnika Inc	Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
US20030220234A1 (en) *	1998-11-02	2003-11-27	Selvaraj Naicker	Deuterated cyclosporine analogs and their use as immunodulating agents
PT1091975E (pt)	1998-07-01	2006-05-31	Debiopharm Sa	Nova ciclosporina com um perfil de actividade melhorado
AU2002333098B2 (en) *	2001-10-19	2006-03-16	Isotechnika Pharma Inc.	Novel cyclosporin analog microemulsion preconcentrates
SI1436321T1 (sl) *	2001-10-19	2006-12-31	Isotechnika Inc	Sinteza analogov ciklosporina
US7538084B2 (en)	2003-03-17	2009-05-26	Amr Technology, Inc.	Cyclosporins
US20060014677A1 (en) *	2004-07-19	2006-01-19	Isotechnika International Inc.	Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
US7511013B2 (en)	2004-09-29	2009-03-31	Amr Technology, Inc.	Cyclosporin analogues and their pharmaceutical uses
US7378391B2 (en)	2004-09-29	2008-05-27	Amr Technology, Inc.	Cyclosporin alkyne analogues and their pharmaceutical uses
EP1812037A4 (en)	2004-10-06	2009-11-11	Amr Technology Inc	ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
US10137083B2 (en)	2006-03-07	2018-11-27	SGN Nanopharma Inc	Ophthalmic preparations
US11311477B2 (en)	2006-03-07	2022-04-26	Sgn Nanopharma Inc.	Ophthalmic preparations
US7696165B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US20080206287A1 (en) *	2006-09-18	2008-08-28	Reed John C	Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
TW200932240A (en)	2007-10-25	2009-08-01	Astellas Pharma Inc	Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
EP2391376A4 (en) *	2009-01-30	2012-08-01	Enanta Pharm Inc	ANALOGUES OF CYCLOSPORIN FOR PREVENTING OR TREATING HEPATITIS C INFECTION
US8481483B2 (en) *	2009-02-19	2013-07-09	Enanta Pharmaceuticals, Inc.	Cyclosporin analogues
US8349312B2 (en) *	2009-07-09	2013-01-08	Enanta Pharmaceuticals, Inc.	Proline substituted cyclosporin analogues
US8685917B2 (en) *	2009-07-09	2014-04-01	Enanta Pharmaceuticals, Inc.	Cyclosporin analogues
US8367053B2 (en)	2009-07-09	2013-02-05	Enanta Pharmaceuticals, Inc.	Cyclosporin analogues
US8623814B2 (en) *	2010-02-23	2014-01-07	Enanta Pharmaceuticals, Inc.	Antiviral agents
US9217015B2 (en)	2010-07-16	2015-12-22	S&T Global Inc.	Cyclosporin derivatives for the treatment and prevention of a viral infection
WO2012021796A2 (en)	2010-08-12	2012-02-16	S&T Global, Inc.	Novel cyclosporin derivatives for the treatment and prevention of a viral infection
US9890198B2 (en)	2010-12-03	2018-02-13	S&T Global Inc.	Cyclosporin derivatives and uses thereof
CN107496902B (zh)	2010-12-15	2022-01-18	康卓维尔制药公司	在氨基酸1和3位修改的环孢菌素类似分子
WO2012145427A1 (en)	2011-04-18	2012-10-26	The Trustees Of Columbia University In The City Of New York	Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2014085623A1 (en)	2012-11-28	2014-06-05	Enanta Pharmaceuticals, Inc.	Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
KR20160045136A (ko)	2013-08-26	2016-04-26	이난타 파마슈티칼스, 인코포레이티드	C형 간염을 예방 또는 치료하기 위한 사이클로스포린 유사체
US9669095B2 (en)	2014-11-03	2017-06-06	Enanta Pharmaceuticals, Inc.	Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2463138C2 (de) *	1973-12-06	1984-07-05	Sandoz-Patent-GmbH, 7850 Lörrach	Das Antibiotikum Cyclosporin B (S 7481/F-2), seine Herstellung und Verwendung

1975
- 1975-11-04 CH CH1419575A patent/CH614931A5/xx not_active IP Right Cessation
1976
- 1976-10-23 DE DE2661031A patent/DE2661031C2/de not_active Expired
- 1976-10-23 DE DE2648121A patent/DE2648121C2/de not_active Expired
- 1976-10-25 ZA ZA00766340A patent/ZA766340B/xx unknown
- 1976-10-26 FI FI763049A patent/FI60701C/fi not_active IP Right Cessation
- 1976-10-26 DK DK483176A patent/DK148907C/da not_active IP Right Cessation
- 1976-10-27 US US05/736,106 patent/US4108985A/en not_active Expired - Lifetime
- 1976-10-27 SE SE7611906A patent/SE432247B/xx unknown
- 1976-10-27 NO NO763667A patent/NO763667L/no unknown
- 1976-10-29 NL NL7612026A patent/NL7612026A/xx not_active Application Discontinuation
- 1976-11-02 CA CA264,703A patent/CA1087609A/en not_active Expired
- 1976-11-02 NZ NZ182496A patent/NZ182496A/xx unknown
- 1976-11-02 PH PH19079A patent/PH14725A/en unknown
- 1976-11-02 JP JP51131314A patent/JPS5259180A/ja active Granted
- 1976-11-02 IE IE2379/81A patent/IE44750B1/en unknown
- 1976-11-02 GB GB19922/79A patent/GB1567202A/en not_active Expired
- 1976-11-02 GB GB45485/76A patent/GB1567201A/en not_active Expired
- 1976-11-02 AU AU19262/76A patent/AU513538B2/en not_active Ceased
- 1976-11-02 IE IE2439/76A patent/IE44749B1/en unknown
- 1976-11-03 AT AT812276A patent/AT359642B/de not_active IP Right Cessation
- 1976-11-03 BE BE172045A patent/BE847941A/xx not_active IP Right Cessation
- 1976-11-03 IL IL50836A patent/IL50836A/xx unknown
- 1976-11-03 YU YU02700/76A patent/YU270076A/xx unknown
- 1976-11-03 PT PT65791A patent/PT65791B/pt unknown
- 1976-11-03 ES ES452942A patent/ES452942A1/es not_active Expired
- 1976-11-04 FR FR7633231A patent/FR2330387A1/fr active Granted
1977
- 1977-04-21 FR FR7711993A patent/FR2338251A1/fr active Granted
1979
- 1979-06-11 CH CH543479A patent/CH619735A5/de not_active IP Right Cessation
1982
- 1982-03-30 SE SE8202039A patent/SE8202039L/sv not_active Application Discontinuation
1986
- 1986-09-11 JP JP61215602A patent/JPS6277399A/ja active Granted

Also Published As

Publication number	Publication date
DK483176A (da)	1977-05-05
YU270076A (en)	1982-05-31
AT359642B (de)	1980-11-25
JPS6210240B2 (hu)	1987-03-05
JPS6277399A (ja)	1987-04-09
NO763667L (hu)	1977-05-05
FR2330387B1 (hu)	1980-03-14
DK148907B (da)	1985-11-11
SE8202039L (sv)	1982-03-30
GB1567201A (en)	1980-05-14
BE847941A (fr)	1977-05-03
FR2338251A1 (fr)	1977-08-12
FI60701C (fi)	1982-03-10
CH619735A5 (hu)	1980-10-15
FI60701B (fi)	1981-11-30
GB1567202A (en)	1980-05-14
IE44750L (en)	1977-05-04
FI763049A (hu)	1977-05-05
SE7611906L (sv)	1977-05-05
DK148907C (da)	1986-04-07
FR2330387A1 (fr)	1977-06-03
NL7612026A (nl)	1977-05-06
CA1087609A (en)	1980-10-14
PT65791B (fr)	1978-07-05
IE44749L (en)	1977-05-04
US4108985A (en)	1978-08-22
CH614931A5 (hu)	1979-12-28
ES452942A1 (es)	1978-01-16
DE2648121C2 (de)	1986-05-28
IE44749B1 (en)	1982-03-24
IL50836A (en)	1979-10-31
JPS5259180A (en)	1977-05-16
NZ182496A (en)	1981-12-15
PT65791A (fr)	1976-12-01
ZA766340B (en)	1978-06-28
JPS6253520B2 (hu)	1987-11-10
ATA812276A (de)	1980-04-15
AU513538B2 (en)	1980-12-11
PH14725A (en)	1981-11-13
FR2338251B1 (hu)	1984-01-13
DE2648121A1 (de)	1977-05-12
AU1926276A (en)	1978-05-11
DE2661031C2 (hu)	1988-05-05
IL50836A0 (en)	1977-01-31
IE44750B1 (en)	1982-03-24

Publication	Publication Date	Title
SE432247B (sv)	1984-03-26	Sett att framstella dihydro-cyklosporin c
SE433222B (sv)	1984-05-14	Sett att framstella modifierad polysackarid
SE422077B (sv)	1982-02-15	Sett att framstella syntesgas
SE426583B (sv)	1983-01-31	Sett att framstella etylidenacetat
SE7606280L (sv)	1976-12-07	Sett att framstella etrar
SE7600277L (sv)	1976-07-15	Sett att framstella sampolymerisatpulver
SE440779B (sv)	1985-08-19	Sett att framstella androstan-17-on-derivat
SE7612532L (sv)	1977-05-12	Sett att framstella grundpalar
SE433492B (sv)	1984-05-28	Sett att framstella fenylettiksyraderivat
SE430887B (sv)	1983-12-19	Sett att framstella vissa substituerade fenylguanidiner
SE441042B (sv)	1985-09-02	Sett att pavisa rheumatoida faktorer
SE420728B (sv)	1981-10-26	Sett att framstella piperazinyliminorifamyciner
SE425736B (sv)	1982-11-01	Sett att framstella kromanon-(4)
SE432256B (sv)	1984-03-26	Sett att framstella cellulosaalkyletrar
SE427111B (sv)	1983-03-07	Sett att framstella pilokarpiniumsalter
SE7606484L (sv)	1976-12-14	Sett att framstella hoghallfasta cementkonglomerat
SE430687B (sv)	1983-12-05	Sett att framstella hexanitrostilben
SE420732B (sv)	1981-10-26	Sett att framstella 4-gonen-3-oner
SE429438B (sv)	1983-09-05	Sett att framstella flexibla sprengemnesformkroppar
SE424991B (sv)	1982-08-23	Sett att framstella nya 5-fenyl-oxazolidinoner
SE430156B (sv)	1983-10-24	Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7609269L (sv)	1977-03-19	Sett att framstella polymerblandningar
SE427655B (sv)	1983-04-25	Sett att framstella abietamidderivat
SE7607171L (sv)	1976-12-28	Sett att framstella indolokinoliziner
SE420690B (sv)	1981-10-26	Sett att kontinuerligt framstella vermeisolerande ledningsror